News
Insider Monkey on MSN2h
AstraZeneca PLC (AZN) Announced Positive Results for its Phase 3 Trial of GefurulimabAstraZeneca PLC (NASDAQ:AZN) is one of the Stocks With Huge Catalysts on the Horizon. On July 24, AstraZeneca PLC (NASDAQ:AZN ...
Revenue from oncology products made up 43 per cent of Astrazeneca's revenue in the first half of 2025, up 15 per cent year on ...
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
(Sharecast News) - London stocks ended lower on Monday, erasing earlier gains as investors reassessed the weekend's trade agreement between the United States and the European Union. The FTSE 100 index ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results